ORCASONIX Ltd.,  Established in 2011, based in Netanya, Israel

Company Overview

Orcasonix is developing a new ultrasound imaging system based on a revolutionary new technology with depth independent resolution up to very great depths and regardless of body habitus. The technology enables extremely low cost hardware implementation with a virtually "unlimited number of channels" at a fraction of a cost-per-channel of current systems and with very efficient signal/image processing which significantly reduces the expenses of computer system.

Orcasonix’s proprietary technology provides a platform on which a whole family of high quality and cost-efficient products can be based. The first of these products has started clinical trials and some others are in early stages of development. The technology is ideally suitable for direct end-user application as well as for OEM implementation by manufacturers of existing products.

Following the completion of the first clinical cases, Orcasonix is in the process of introducing its revolutionary solution to the world of ultrasound imaging. Orcasonix’s current product will be for general abdominal imaging of obese and overweight patients, however, the company is open to other additional applications.

Market Size and Description

Among Americans age 20 and older, 154.7 million are overweight or obese (BMI of 25 kg/m2 and higher). Of these, 78.4 million are obese (BMI of 30 kg/m2 and higher). 

Over 22 million abdominal ultrasound exams were performed in 2012. Estimated of up to 10 % of abdominal ultrasound exams are non-diagnostic due to obesity => Potential of $220 M annually.

Additionally, more obese patients will be referred to abdominal U/S tests upon availability of  better imaging capabilities. Among the potential patient population, half a billion people globally are considered obese with limited Ultrasound imaging solutions.

Management Team

  Mati Shirizly,CEO – EE, brings over 25 years of experience in R&D, business development and marketing in signal processing and Synthetic Aperture imaging.

  Alex Lomes,CTO PhD., brings over 35 years of experience in R&D and project management; in acoustics, antenna design, signal and image processing (specifically in the fields of Phased Array and Synthetic Aperture systems).

Company Advisors

  Michael Blaivas, - MD, FACEP, FAIUM, Professor of Emergency Medicine, Associate Professor of Internal Medicine, Member, AIUM Executive Committee, President, Society of Ultrasound in Medical Education, Editor-in-Chief, Critical Ultrasound Journal, Chair, AIUM Emergency and Critical Care Ultrasound Section, Immediate Past President, WINFOCUS, Sub-specialty Editor, Journal of Ultrasound in Medicine, Alternate, Delegate to the American Medical Association, Department of Emergency Medicine, Northside Hospital Forsyth Atlanta, Georgia.

  Chris M.W Daft, - PhD., chief scientist of Cephasonics Inc. Chris is well known expert in the ultrasound industry. He has worked for industry leaders GE and SIEMENS for about 20 years. During 2005-2011 Chris led the engineering efforts in SIEMENS (ultrasound) as a senior manager, and was nominated as key-expert of the company.

  Pinchas Daniel Lebensart, - M.D, Associate Clinical Professor of Diagnostic Radiology, Hebrew University Hadassah Medical School. For 31 years Chief, Ultrasound Unit, Radiology Department, Hadassah University Hospital, Ein Kerem Israel. Areas Of Interest: Ultrasound-guided biopsy and drainage procedures, particularly in the thyroid, parathyroid, neck, gallbladder, and liver.

  Dov Maor, - DSc. and MSc., Served as VP of Clinical Marketing at InSightec, Ltd. and VP of Clinical Research and Regulatory Affairs (1999-2010), He served as Chief Scientist and VP Technology of Elscint. (1987-1998). Dov has extensive experience in all fields of medical imaging.